Antimicrobial activities of BMS-284756 compared with those of fluoroquinolones and β-lactams against gram-positive clinical isolates

被引：20

作者：

Bassetti, M

Dembry, LM

Farrel, PA

Callan, DA

Andriole, VT

机构：

[1] Yale New Haven Med Ctr, New Haven, CT 06504 USA

[2] Yale Univ, Sch Med, New Haven, CT USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2002年 / 46卷 / 01期

关键词：

D O I：

10.1128/AAC.46.1.234-238.2002

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The in vitro antibacterial activity of BMS-284756 was compared to those of ciprofloxacin, gatifloxacin, moxifloxacin, ceftriaxone, imipenem, piperacillin-tazobactam, and amoxicillin-clavulanic acid against 492 gram-positive clinical isolates. BMS-284756 was the most-active agent against Streptococcus pneumoniae, Streptococcus viridans, beta-hemolytic streptococci, methicillin-sensitive and -resistant Staphylococcus aureus, methicillin-sensitive and -resistant coagulase-negative staphylococci, and enterococci.

引用

页码：234 / 238

页数：5

共 16 条

[1] Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin
Bauernfeind, A
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (05) : 639 - 651
[2] Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms
Blondeau, JM
Laskowski, R
Bjarnason, J
Stewart, C
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 14 (01) : 45 - 50
[3] RAPID DEVELOPMENT OF CIPROFLOXACIN RESISTANCE IN METHICILLIN-SUSCEPTIBLE AND METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS
BLUMBERG, HM
RIMLAND, D
CARROLL, DJ
TERRY, P
WACHSMUTH, IK
[J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (06) : 1279 - 1285
[4] EVALUATION OF THE E-TEST, A NOVEL METHOD OF QUANTIFYING ANTIMICROBIAL ACTIVITY
BROWN, DFJ
BROWN, L
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (02) : 185 - 190
[5] Antimicrobial activity of gatifloxacin compared to seven other compounds tested against gram-positive organisms isolated at 10 cancer-treatment centers
Diekema, DJ
Jones, RN
Rolston, KVI
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 34 (01) : 37 - 43
[6] Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756
Fung-Tomc, JC
Minassian, B
Kolek, B
Huczko, E
Aleksunes, L
Stickle, T
Washo, T
Gradelski, E
Valera, L
Bonner, DP
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) : 3351 - 3356
[7] HUMPHREYS H, 1985, LANCET, V2, P383
[8] Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation
Jones, RN
Johnson, DM
Erwin, ME
Beach, ML
Biedenbach, DJ
Pfaller, MA
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 34 (02) : 91 - 98
[9] In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: Data from the SENTRY antimicrobial surveillance program
Jones, RN
Pfaller, MA
[J]. CLINICAL INFECTIOUS DISEASES, 2000, 31 : S16 - S23
[10] Activity and spectrum of BMS 284756, a new des-F (6) quinolone, tested against strains of ciprofloxacin-resistant Gram-positive cocci
Jones, RN
Pfaller, MA
Stilwell, M
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 39 (02) : 133 - 135

← 1 2 →